Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2000
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000EP0714418B1 Cosmetic melanins
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/25/2000CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same
10/25/2000CN1271349A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271341A Substituted 2-pyrolidinone activators of PKC
10/25/2000CN1271292A Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
10/25/2000CN1271283A Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1271278A Treatment of conduct disorder
10/25/2000CN1271250A Polyamine treatment of neurological disorders
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270824A Tonic wine capable of promoting blood circulation
10/25/2000CN1270820A Tonic compound deer fetus ointment and its preparation
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/25/2000CN1057771C Androstenone derivative
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/25/2000CN1057688C Physiological balancing agent for livestock and fowls
10/24/2000US6136969 Azepanes
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136845 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136842 Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136833 Pharmaceutical formulations and process for their preparation
10/24/2000US6136832 Racemic mixtures and enantiomorphs
10/24/2000US6136829 Nitric oxide synthetase inhibitors
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136805 Quinoxaline dione derivatives, their production and their use in medicaments
10/24/2000US6136803 Cycloalkyl ether indanamine compounds
10/24/2000US6136800 Steroids
10/24/2000US6136799 Cosolvent formulations
10/24/2000US6136796 Drugs for antiischemic agents, strokes, antiepileptic agents and antiasthma agents
10/24/2000US6136791 Viricides and anticarcinogenic agents
10/24/2000US6136790 Carbohydrate mimetics having antiadhesive properties
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136532 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/24/2000US6136333 By exposing tissue to chain extended, coupled or crosslinked polylactone-polyoxyalkylene glycol triblock or diblock having given ethylene oxide:lactoyl(ester) ratio, which provides a barrier to prevent or reduce the extent of adhesions forming
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000US6136294 Amino acid stabilized medical aerosol formulation
10/24/2000CA2221148C Muscle trophic factor
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/24/2000CA2021547C Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061783A2 Process for preparing inhibitors of nucleoside metabolism
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061743A1 Apoptosis-associated gene
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061597A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061582A1 Substituted fused imidazole derivatives
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence
10/19/2000WO2000061552A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-α PRODUCTION INHIBITOR
10/19/2000WO2000061549A2 Pharmaceutical compounds
10/19/2000WO2000061548A1 N-substituted-n'-substituted urea derivative and medicinal compositions containing the same
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000WO2000061230A2 Estrogen receptors-beta antagonism and bone diseases
1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 1564